Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Primary Progressive Aphasia (disorder)
0.040 Biomarker disease BEFREE Plasma neurofilament light chain (NFL) has been proposed as a potential biomarker for PPA. 31640103 2019
Primary Progressive Aphasia (disorder)
0.040 GeneticVariation disease BEFREE Elevated baseline neurofilament light chain predicted faster worsening in clinical severity, frontotemporal volume and frontotemporal fractional anisotropy in patients with behavioral variant frontotemporal dementia and nonfluent variant primary progressive aphasia. 30349860 2018
Primary Progressive Aphasia (disorder)
0.040 AlteredExpression disease BEFREE We investigated neurofilament light chain (NF-L) levels in blood of 99 patients with PPA (40 with nonfluent variant PPA [nfvPPA], 38 with semantic variant PPA [svPPA], 21 with logopenic variant PPA [lvPPA]) and compared diagnostic performance with that reached by CSF NF-L, phosphorylated neurofilament heavy chain (pNF-H), β-amyloid (Aβ<sub>1-42</sub>), tau, and phosphorylated tau. 28179468 2017
Primary Progressive Aphasia (disorder)
0.040 Biomarker disease BEFREE We analyzed 3 CSF biomarkers (YKL-40, soluble β fragment of amyloid precursor protein [sAPPβ], neurofilament light [NfL]) and core Alzheimer disease (AD) biomarkers (β-amyloid<sub>1-42</sub>, total tau, phosphorylated tau) in patients with FTLD-related clinical syndromes (n = 159): behavioral variant of frontotemporal dementia (n = 68), nonfluent (n = 23) and semantic (n = 19) variants of primary progressive aphasia, progressive supranuclear palsy (n = 28), and corticobasal syndrome (n = 21). 28592456 2017